Getinge AB (publ) (GNGBF)
- Previous Close
21.25 - Open
21.17 - Bid --
- Ask --
- Day's Range
21.17 - 21.17 - 52 Week Range
16.76 - 24.50 - Volume
150 - Avg. Volume
19 - Market Cap (intraday)
5.732B - Beta (5Y Monthly) 0.56
- PE Ratio (TTM)
27.49 - EPS (TTM)
0.77 - Earnings Date --
- Forward Dividend & Yield 0.40 (1.91%)
- Ex-Dividend Date Apr 23, 2024
- 1y Target Est
--
Getinge AB (publ) provides products and solutions for operating rooms, intensive-care units, and sterilization departments. The company operates through Acute Care Therapies, Life Science, and Surgical Workflows segments. It offers extracorporeal membrane oxygenation, mechanical ventilation, mechanical circulatory support, advanced patient monitoring, ICU infrastructure equipment, patient flow management, and drainage solutions. The company also provides surgical perfusion, endoscopic vessel harvesting, intra-aortic balloon counterpulsation, and drainage solutions; and operating room infrastructure equipment, anesthesia, advanced patient monitoring, operating room management, and operating room integration solutions. In addition, it offers pre-cleaning, cleaning and disinfection, sterilization, consumables, endoscope reprocessing, and sterile supply management solutions; connected medical devices; bioreactor systems, DPTE systems, Getinge isolators, terminal sterilization products, and sterilizers; and vivarium, biohazardous materials handling solutions, labware cleaning and sterilization, upstream bioprocessing, and bioreactor preparation solutions. It offers its products through a network of sales companies, as well as through agents and distributors in the Americas, Europe, the Middle East, Africa, and the Asia and Pacific. Getinge AB (publ) was founded in 1904 and is headquartered in Gothenburg, Sweden.
www.getinge.comRecent News: GNGBF
Performance Overview: GNGBF
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: GNGBF
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: GNGBF
Valuation Measures
Market Cap
5.88B
Enterprise Value
6.34B
Trailing P/E
27.45
Forward P/E
22.42
PEG Ratio (5yr expected)
2.64
Price/Sales (ttm)
1.95
Price/Book (mrq)
1.94
Enterprise Value/Revenue
0.20
Enterprise Value/EBITDA
1.10
Financial Highlights
Profitability and Income Statement
Profit Margin
7.10%
Return on Assets (ttm)
4.15%
Return on Equity (ttm)
7.22%
Revenue (ttm)
32.2B
Net Income Avi to Common (ttm)
2.28B
Diluted EPS (ttm)
0.77
Balance Sheet and Cash Flow
Total Cash (mrq)
3.36B
Total Debt/Equity (mrq)
25.55%
Levered Free Cash Flow (ttm)
2.49B
Company Insights: GNGBF
GNGBF does not have Company Insights